BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36672274)

  • 1. The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.
    Zayat V; Kuczynska Z; Liput M; Metin E; Rzonca-Niewczas S; Smyk M; Mazurczak T; Goszczanska-Ciuchta A; Leszczynski P; Hoffman-Zacharska D; Buzanska L
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
    Schuster J; Fatima A; Sobol M; Norradin FH; Laan L; Dahl N
    Stem Cell Res; 2019 Aug; 39():101523. PubMed ID: 31400703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.
    Schuster J; de Guidi C; Tripathi R; Klar J; Dahl N
    Stem Cell Res; 2022 Apr; 60():102712. PubMed ID: 35203050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of iPSC lines (KAIMRCi003A, KAIMRCi003B) from a Saudi patient with Dravet syndrome carrying homozygous mutation in the CPLX1 gene and heterozygous mutation in SCN9A.
    Alowaysi M; Al-Shehri M; Badkok A; Attas H; Aboalola D; Baadhaim M; Alzahrani H; Daghestani M; Zia A; Al-Ghamdi K; Al-Ghamdi A; Zakri S; Aouabdi S; Tegner J; Alsayegh K
    Hum Cell; 2024 Mar; 37(2):502-510. PubMed ID: 38110787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
    Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
    Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
    Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
    Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.
    Maeda H; Chiyonobu T; Yoshida M; Yamashita S; Zuiki M; Kidowaki S; Isoda K; Yamakawa K; Morimoto M; Nakahata T; Saito MK; Hosoi H
    J Hum Genet; 2016 Jun; 61(6):565-9. PubMed ID: 26841829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
    Shan W; Yang X; Ren Q; Wang Q
    Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
    Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
    Elife; 2016 Jul; 5():. PubMed ID: 27458797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.
    Jiao J; Yang Y; Shi Y; Chen J; Gao R; Fan Y; Yao H; Liao W; Sun XF; Gao S
    Hum Mol Genet; 2013 Nov; 22(21):4241-52. PubMed ID: 23773995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
    Hoffman-Zacharska D; Szczepanik E; Terczynska I; Goszczanska-Ciuchta A; Zalewska-Miszkurka Z; Tataj R; Bal J
    Neurol Neurochir Pol; 2015; 49(4):258-66. PubMed ID: 26188943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene.
    Tanaka Y; Higurashi N; Shirasu N; Yasunaga S; Moreira KM; Okano H; Hirose S
    Stem Cell Res; 2018 Aug; 31():11-15. PubMed ID: 29981888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
    Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
    Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes.
    Frasier CR; Zhang H; Offord J; Dang LT; Auerbach DS; Shi H; Chen C; Goldman AM; Eckhardt LL; Bezzerides VJ; Parent JM; Isom LL
    Stem Cell Reports; 2018 Sep; 11(3):626-634. PubMed ID: 30146492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal manipulation of the Scn1a gene reveals its essential role in adult brain function.
    Di Berardino C; Mainardi M; Brusco S; Benvenuto E; Broccoli V; Colasante G
    Brain; 2024 Apr; 147(4):1216-1230. PubMed ID: 37812819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome.
    Ogiwara I; Iwasato T; Miyamoto H; Iwata R; Yamagata T; Mazaki E; Yanagawa Y; Tamamaki N; Hensch TK; Itohara S; Yamakawa K
    Hum Mol Genet; 2013 Dec; 22(23):4784-804. PubMed ID: 23922229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
    Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M
    Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCN1A/Na
    Mantegazza M; Broccoli V
    Epilepsia; 2019 Dec; 60 Suppl 3():S25-S38. PubMed ID: 31904127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
    Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
    Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.